Evidence map›Paper›PMID 20628624›Full record

ArticlePLoS genetics2010

Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".

Sharon E Johnatty, Jonathan Beesley, Xiaoqing Chen, Stuart Macgregor, David L Duffy, Amanda B Spurdle, Anna deFazio, Natalie Gava, Penelope M Webb, Mary Anne Rossing and 48 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 3 pooled it
11.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 3 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Prediagnosis Leukocyte Telomere Length and Risk of Ovarian Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2017
    Article
  10. Article
  11. Article
  12. Article
  13. TERT polymorphisms rs2853669 and rs7726159 influence on prostate cancer risk in Russian population.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  14. Article
  15. Review
  16. Article
  17. Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2013
    Review
  18. Article
  19. Genome-wide association study for ovarian cancer susceptibility using pooled DNA.Twin research and human genetics : the official journal of the International Society for Twin Studies · 2012
    Article
  20. Telomere length and genetic variation in telomere maintenance genes in relation to ovarian cancer risk.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

58 authors at 16 institutions in 6 countries.

Sharon E JohnattyQueensland Institute of Medical Research, Brisbane, Australia. sharonJo@qimr.edu.au
Jonathan Beesley
Xiaoqing Chen
Stuart Macgregor
David L Duffy
Amanda B Spurdle
Anna deFazio
Natalie Gava
Penelope M Webb
Mary Anne Rossing
Jennifer Anne Doherty
Marc T Goodman
Galina Lurie
Pamela J Thompson
Lynne R Wilkens
Roberta B Ness
Kirsten B Moysich
Jenny Chang-Claude
Shan Wang-Gohrke
Daniel W Cramer
Kathryn L Terry
Susan E Hankinson
Shelley S Tworoger
Montserrat Garcia-Closas
Hannah Yang
Jolanta Lissowska
Stephen J Chanock
Paul D Pharoah
Honglin Song
Alice S Whitemore
Celeste L Pearce
Daniel O Stram
Anna H Wu
Malcolm C Pike
Simon A Gayther
Susan J Ramus
Usha Menon
Aleksandra Gentry-Maharaj
Hoda Anton-Culver
Argyrios Ziogas
Estrid Hogdall
Susanne K Kjaer
Claus Hogdall
Andrew Berchuck
Joellen M Schildkraut
Edwin S Iversen
Patricia G Moorman
Catherine M Phelan
Thomas A Sellers
Julie M Cunningham
Robert A Vierkant
David N Rider
Ellen L Goode
Izhak Haviv
Georgia Chenevix-Trench
Ovarian Cancer Association Consortium
Australian Ovarian Cancer Study Group
Australian Cancer Study (Ovarian Cancer)
QIMR Berghofer Medical Research Institute · AUBrigham and Women's Hospital · USMayo Clinic · USUniversity of Hawaiʻi at Mānoa · USUniversity of Southern California · USUniversity of Copenhagen · DKThe University of Sydney · AUUniversity of California, Irvine · USUniversity of Cambridge · GBDuke Medical Center · USMoffitt Cancer Center · USNational Cancer Institute · USUniversity College London · GBBaker Heart and Diabetes Institute · AUGerman Cancer Research Center · DERoswell Park Comprehensive Cancer Center · US

Funding

Novel Serum, Plasma, and Urine Biomarkers of Ovarian CanP50CA105009 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI CRAMER, DANIEL WILLIAM · 2004 to 2010
$13.3M
OVARIAN CANCER RISK AND HYPERGONADOTROPIC HYPOGONADISMR01CA054419 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI CRAMER, DANIEL WILLIAM · 1992 to 2007
$5.9M
COLLABORATIVE STUDY OF OVARIAN CANCER IN TWO RISK GROUPSR01CA058598 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI GOODMAN, MARC T · 1993 to 2012
$4.6M
Epidemiology of Ovarian Cancer:New HypothesesR01CA087538 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ROSSING, MARY ANNE · 2002 to 2006
$3.5M
Steroid Hormone Genes and Ovarian Cancer RiskR01CA112523 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ROSSING, MARY ANNE · 2006 to 2010
$3.3M
HEREDITARY BREAST CANCER--GENETIC AND MOLECULAR STUDIESR01CA058860 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI ANTON-CULVER, HODA A · 1994 to 2008
$3.1M
Inflammation and Ovarian CancerR01CA095023 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BUNKER, CLAREANN H. · 2003 to 2008
$2.7M
Genetic Variation in the NF-kappaB Pathway and Ovarian Cancer EtiologyR01CA122443 · NCI · MAYO CLINIC ROCHESTER · PI GOODE, ELLEN L. · 2007 to 2012
$2.7M
HEREDITARY BREAST CANCER--GENETIC AND MOLECULAR STUDIESU01CA058860 · NCI · UNIVERSITY OF CALIFORNIA IRVINE · PI ANTON-CULVER, HODA A. · 1997 to 2002
$2.5M
Hormonal Factors in Invasive and LMP Ovarian CancersK07CA092044 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI BREWSTER, WENDY ROSAMUND · 2003 to 2006
$509k
Cancer Research UK 10119Cancer Research UK 10124Cancer Research UK 11021Cancer Research UK A10119Cancer Research UK A10124Medical Research Council G0801875NCI NIH HHS CA-58860NCI NIH HHS CA-92044NCI NIH HHS K07 CA092044NCI NIH HHS P50 CA105009NCI NIH HHS P50CA105009NCI NIH HHS R01 CA054419NCI NIH HHS R01 CA058598NCI NIH HHS R01 CA058860NCI NIH HHS R01 CA087538NCI NIH HHS R01 CA095023NCI NIH HHS R01CA095023NCI NIH HHS R01 CA112523NCI NIH HHS R01CA112523NCI NIH HHS R01 CA122443NCI NIH HHS R01-CA122443NCI NIH HHS R01CA54419NCI NIH HHS R01 CA87538NCI NIH HHS U01 CA058860
6 · The paper itself

Abstract

We hypothesized that variants in genes expressed as a consequence of interactions between ovarian cancer cells and the host micro-environment could contribute to cancer susceptibility. We therefore used a two-stage approach to evaluate common single nucleotide polymorphisms (SNPs) in 173 genes involved in stromal epithelial interactions in the Ovarian Cancer Association Consortium (OCAC). In the discovery stage, cases with epithelial ovarian cancer (n=675) and controls (n=1,162) were genotyped at 1,536 SNPs using an Illumina GoldenGate assay. Based on Positive Predictive Value estimates, three SNPs-PODXL rs1013368, ITGA6 rs13027811, and MMP3 rs522616-were selected for replication using TaqMan genotyping in up to 3,059 serous invasive cases and 8,905 controls from 16 OCAC case-control studies. An additional 18 SNPs with Pper-allele<0.05 in the discovery stage were selected for replication in a subset of five OCAC studies (n=1,233 serous invasive cases; n=3,364 controls). The discovery stage associations in PODXL, ITGA6, and MMP3 were attenuated in the larger replication set (adj. Pper-allele>or=0.5). However genotypes at TERT rs7726159 were associated with ovarian cancer risk in the smaller, five-study replication study (Pper-allele=0.03). Combined analysis of the discovery and replication sets for this TERT SNP showed an increased risk of serous ovarian cancer among non-Hispanic whites [adj. ORper-allele 1.14 (1.04-1.24) p=0.003]. Our study adds to the growing evidence that, like the 8q24 locus, the telomerase reverse transcriptase locus at 5p15.33, is a general cancer susceptibility locus.

Indexed as

Polymorphism, Single NucleotideCase-Control StudiesChromosomes, Human, Pair 5Epithelial CellsFemaleGenetic Predisposition to DiseaseGenotypeHumansOvarian NeoplasmsStromal CellsTelomeraseWhite PeopleTelomerase

Identifiers

PMID20628624
PMCPMC2900295
OpenAlexW2139055031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.